Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort Study

Authors:

Abstract
There is a large body of evidence indicating that 4 to 5% of solid organ transplant recipients develop a malignancy after transplantation, which corresponds to an approximately two- to four-fold elevated risk compared to the general population.